Newsroom | US Fertility launches Research Division to further advance scientific and medical research in the field of reproductive medicine
US Fertility launches Research Division to further advance scientific and medical research in the field of reproductive medicine
US Fertility’s Research Division will conduct and publish high-quality research studies to continually and safely push boundaries in science, technology, and innovation in order to better serve patients and improve pregnancy outcomes.
Rockville, MD [October 20, 2022] – US Fertility’s newly formed Research Division will conduct and publish high-quality research studies to advance the field of reproductive medicine to provide better, more effective care to patients in the future.
US Fertility’s Research Division will be led by Kate Devine, M.D., Executive Medical Director and Chief Research Officer at US Fertility, in close collaboration with Luis Hoyos, M.D., Regional Research Director and practicing reproductive endocrinologist (REI) at US Fertility founding partner practice IVF Florida; Michael Homer, M.D., Regional Research Director and practicing REI at US Fertility founding partner practice, Reproductive Science Center of the San Francisco Bay Area (RSC); Meike Uhler, M.D., Regional Research Director and practicing reproductive endocrinologist (REI) at US Fertility founding partner practice Fertility Centers of Illinois (FCI); Samad Jahandideh, Ph.D., Head of Clinical Biostatistics at US Fertility, and others.
US Fertility is the largest network of physician-owned and physician-led fertility practices in the nation. With more than 130,000 babies born to its credit, US Fertility completes more than 30,000 fresh IVF cycles annually, nearly 70,000 cycles total, include frozen embryo transfers, and performs 1,000+ elective and donor egg freezing cycles annually.
“Given our culture, commitment to excellence, incredible volume of data, and unparalleled talent, there’s no limit to what we can accomplish as a network,” shares Dr. Devine. “Our Research Division celebrates the amazing contributions our research and education teams are making in collaboration across the US Fertility network, a network of innovation.”
Dr. Devine is a practicing, board-certified reproductive endocrinologist and fertility physician at Shady Grove Fertility, a founding partner practice of US Fertility. Dr. Devine also serves as faculty to fellows at the National Institutes of Health (NIH) and to residents at Georgetown School of Medicine. Dr. Devine is the Quality Assurance Chair for the Society for Assisted Reproductive Technology (SART) as well as a Research Chair for the Society for Reproductive Endocrinology and Infertility (SREI). She serves on the Medical Executive Committee for the Jones Foundation and on the Editorial Board for Fertility and Sterility.
US Fertility’s Research Division announcement arrives as the organization gears up for a significant presence at the upcoming annual American Society for Reproductive Medicine (ASRM) Scientific Congress and Expo, which will take place from October 23-26, 2022, in Anaheim, California. Researchers from across the US Fertility network are showcasing abstracts, delivering oral presentations, and receiving research prizes during the event.
“Our team is hard at work educating the next generation of providers and embryologists to care for future patients struggling with infertility. 2022 represents the showing of some of our best research to date,” shares Dr. Devine. “I feel so privileged to work at an organization that values research and helps facilitate this amazing work.”
Visit the US Fertility Research Division landing page to learn more about the program and discover the latest research in the field of reproductive medicine. Contact email@example.com to become involved or to connect with the research team.
About US Fertility
US Fertility is the nation’s largest partnership of physician-owned and physician-led top-tier fertility practices in the United States, offering comprehensive fertility-market-focused non-clinical, administrative, and technical platforms that help domestic and international practices improve patient outcomes and increase patient access. To learn more about partnership- or affiliate-status benefits, call 301-545-1308 or visit USFertility.com.